title: Neonatal hemolytic anemia due to inherited harderoporphyria: clinical characteristics and molecular basis.
abstract: Porphyrias, a group of inborn errors of heme synthesis, are classified as hepatic or erythropoietic according to clinical data and the main site of expression of the specific enzymatic defect. Hereditary coproporphyria (HC) is an acute hepatic porphyria with autosomal dominant inheritance caused by deficient activity of coproporphyrinogen III oxidase (COX). Typical clinical manifestations of the disease are acute attacks of neurological dysfunction; skin photosensitivity may also be present. We report a variant form of HC characterized by a unifying syndrome in which hematologic disorders predominate: harderoporphyria. Harderoporphyric patients exhibit jaundice, severe chronic hemolytic anemia of early onset associated with hepatosplenomegaly, and skin photosensitivity. Neither abdominal pain nor neuropsychiatric symptoms are observed. COX activity is markedly decreased. In a first harderoporphyric family, with three affected siblings, a homozygous K404E mutation has been previously characterized. In the present study, molecular investigations in a second family with neonatal hemolytic anemia and harderoporphyria revealed two heterozygous point mutations in the COX gene. One allele bore the missense mutation K404E previously described. The second allele bore an A-->G transition at the third position of the donor splice site in intron 6. This new COX gene mutation resulted in exon 6 skipping and the absence of functional protein production. In contrast with other COX gene defects that produce the classical hepatic porphyria presentation, our data suggest that the K404E substitution (either in the homozygous or compound heterozygous state associated with a mutation leading to the absence of functional mRNA or protein) is responsible for the specific hematologic clinical manifestations of harderoporphyria.
authors.affiliation: Centre Français des Porphyries, INSERM U409, Hôpital Louis Mourier, Colombes, France.
authors.forename: J
authors.initials: J
authors.lastname: Lamoril
authors.forename: H
authors.initials: H
authors.lastname: Puy
authors.forename: L
authors.initials: L
authors.lastname: Gouya
authors.forename: R
authors.initials: R
authors.lastname: Rosipal
authors.forename: V
authors.initials: V
authors.lastname: Da Silva
authors.forename: B
authors.initials: B
authors.lastname: Grandchamp
authors.forename: T
authors.initials: T
authors.lastname: Foint
authors.forename: B
authors.initials: B
authors.lastname: Bader-Meunier
authors.forename: J P
authors.initials: JP
authors.lastname: Dommergues
authors.forename: J C
authors.initials: JC
authors.lastname: Deybach
authors.forename: Y
authors.initials: Y
authors.lastname: Nordmann
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D000745:Anemia, Hemolytic, Congenital / Q000235:genetics* / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D003304:Coproporphyrinogen Oxidase / Q000235:genetics*; D005260:Female; D006720:Homozygote; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D010375:Pedigree; D017354:Point Mutation; D017094:Porphyrias, Hepatic / Q000150:complications / Q000235:genetics* / Q000503:physiopathology
chemical_list: D003304:Coproporphyrinogen Oxidase